Estefanı́a Méndez-Álvarez

Author

Universidade de Santiago de Compostela ORCID

Also Known As

E Méndez-Alvarez, E. Mendez-Alvarez, E. Mendez‐Alvarez, E. Méndez‐Alvarez, Estefania Mendez-Alvarez, Estefania Mendez-alvarez, Estefania Méndez-Alvarez, EstefanÍA Méndez-alvarez, Estefanía Méndez-Álvarez, Estefanía Méndez‐Alvarez

Publications

2.5K

Citations

H-Index

Concepts

All Affiliations

Universidade de Santiago de Compostela University of Bari Aldo Moro Biomedical Research Networking Center on Neurodegenerative Diseases Peoples' Friendship University of Russia University of Lausanne

About

Estefanı́a Méndez-Álvarez is an author at Universidade de Santiago de Compostela specializing in medicine, pharmacology, and neuropharmacology.

Top Concepts

#	Concept	H-Index	Publications	Citations
1	Medicine	24	29	1.7K
2	Biochemistry	13	14	766
3	Social Sciences	9	9	435
4	Natural Sciences	8	8	520
5	Health Sciences	1	1	32

Estefanı́a Méndez-Álvarez

Publications

2.4K

Citations

H-Index

Page 1

	Year	Citations
Autoxidation and Neurotoxicity of 6‐Hydroxydopamine in the Presence of Some Antioxidants Ramón Soto‐Otero, Estefanı́a Méndez-Álvarez, Á. Hermida Ameijeiras, Journal of Neurochemistry	2000	309
Effects of (−)-nicotine and (−)-cotinine on 6-hydroxydopamine-induced oxidative stress and neurotoxicity: relevance for Parkinson’s disease Ramón Soto‐Otero, Estefanı́a Méndez-Álvarez, Á. Hermida Ameijeiras, Biochemical Pharmacology 6-Hydroxydopamine-induced Oxidative StressMedicineNicotineParkinson ’Neuropharmacology	2002	145
Antioxidant properties of dimethyl sulfoxide and its viability as a solvent in the evaluation of neuroprotective antioxidants Carolina Sanmartín‐Suárez, Ramón Soto‐Otero, Inés Sánchez‐Sellero, Journal of Pharmacological and Toxicological Methods Neuroprotective AntioxidantsDimethyl SulfoxideBiochemistryMedicineLipid Peroxidation	2010	136
A QSAR Model for in Silico Screening of MAO-A Inhibitors. Prediction, Synthesis, and Biological Assay of Novel Coumarins Lourdes Santana, Eugenio Uriarte, Humberto González‐Díaz, Journal of Medicinal Chemistry Drug TargetOrganic ChemistryPharmacotherapyChemistrySilico Screening	2005	135
Structural Insights into Monoamine Oxidase Inhibitory Potency and Selectivity of 7-Substituted Coumarins from Ligand- and Target-Based Approaches Marco Catto, Orazio Nicolotti, Francesco Leonetti, Journal of Medicinal Chemistry	2006	107
Angiotensin‐converting enzyme inhibition reduces oxidative stress and protects dopaminergic neurons in a 6‐hydroxydopamine rat model of Parkinsonism Ana Marı́a López-Real, P. Rey, Ramón Soto‐Otero, Journal of Neuroscience Research	2005	106
Discovery of a Novel Class of Potent Coumarin Monoamine Oxidase B Inhibitors: Development and Biopharmacological Profiling of 7-[(3-Chlorobenzyl)oxy]-4-[(methylamino)methyl]-2<i>H</i>-chromen-2-one Methanesulfonate (NW-1772) as a Highly Potent, Selective, Reversible, and Orally Active Monoamine Oxidase B Inhibitor Leonardo Pisani, Giovanni Muncipinto, Teresa Fabiola Miscioscia, Journal of Medicinal Chemistry	2009	105
Structure-Based Design and Optimization of Multitarget-Directed 2<i>H</i>-Chromen-2-one Derivatives as Potent Inhibitors of Monoamine Oxidase B and Cholinesterases Roberta Farina, Leonardo Pisani, Marco Catto, Journal of Medicinal Chemistry PharmacotherapyChemical BiologyPharmaceutical ChemistryMedicinal ChemistryStructure-based Design	2015	98
Effects of aluminum and zinc on the oxidative stress caused by 6-hydroxydopamine autoxidation: relevance for the pathogenesis of Parkinson’s disease Estefanı́a Méndez-Álvarez, Ramón Soto‐Otero, Á. Hermida Ameijeiras, Biochimica et Biophysica Acta (BBA) - Molecular Basis of Disease Neurodegenerative Diseases6-Hydroxydopamine AutoxidationMedicineParkinson ’Nutritional Neuroscience	2002	90
Reduction of dopaminergic degeneration and oxidative stress by inhibition of angiotensin converting enzyme in a MPTP model of parkinsonism Ana Muñoz, P. Rey, María J. Guerra, Neuropharmacology Dopaminergic DegenerationNeurodegenerative DiseasesMptp ModelNeuropeptidesMedicine	2006	89

Page 1